Literature DB >> 12860327

Normal pregnancy and oxygenation during sleep.

G Trakada1, V Tsapanos, K Spiropoulos.   

Abstract

Pregnancy is associated with significant alterations in respiratory function. Changes during pregnancy include reduced functional residual capacity (FRC) and residual volume (RV), increased alveolar-arterial difference for oxygen (A-alphaPO2) and in the supine position, reduced cardiac output. In conjunction with sleep-related apneas or hypopneas, these could lead to maternal oxygen desaturation during sleep. Because of the conflicting data from sleep studies in late pregnancy, we performed complete polysomnography on 11 pregnant women at 36 weeks of gestation and again postpartum. We also measured the PaO2, every 2h. The frequency of apneas and hypopneas was significantly lower during pregnancy compared with that on the postpartum control night. PaO2 levels in the supine position, during sleep, were also significantly lower during pregnancy compared to the postpartum period. No correlation was observed between PaO2 levels and apneas or hypopneas or percent of REM sleep.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860327     DOI: 10.1016/s0301-2115(03)00100-3

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  2 in total

1.  Central sleep apnea in pregnant women with sleep disordered breathing.

Authors:  Ghada Bourjeily; Katherine M Sharkey; Jeffrey Mazer; Robin Moore; Susan Martin; Richard Millman
Journal:  Sleep Breath       Date:  2015-01-08       Impact factor: 2.816

2.  Association between depressive symptoms and poor sleep quality among pregnant women in Northern Rural Bangladesh: a community-based cross-sectional study.

Authors:  Md Mahbubul Alam Shaun; Md Wahidur Rahman Nizum; Md Sabbir Ahmed; Sanjana Zaman; Sujan Kanti Mali; Mohammad Delwer Hossain Hawlader; Md Asaduzzaman Shuvo; Fahmida Fayeza; Md Omar Faruk; Md Fakrul Alam
Journal:  BMC Psychiatry       Date:  2022-03-19       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.